Delivery Order SPE2DB22D3501-SPE2DB25FXH27
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $1,842.17 to AmerisourceBergen Drug Corp for the supply of Abilify Maintena ER 400 mg syringes. This firm fixed price contract, awarded on August 1, 2025, with an ultimate completion date of August 4, 2025, represents a competitively awarded, non-set-aside procurement. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 1, 2025, for the supply of Abilify Maintena ER 300 mg vials/syringes with a ceiling value of $1,382.47. This is a firm fixed-price delivery order with no set-aside designation, competitively awarded to support federal medical procurement needs. The order is scheduled for completion by August 4, 2025, with performance at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This...
- The Defense Logistics Agency awarded a delivery order valued at $1,842.17 to AmerisourceBergen Drug Corp for the supply of Abilify Maintena ER 400 mg syringes. This firm fixed price delivery order was competitively awarded without set-aside designation and is set for completion by August 13, 2025. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, will perform the work at its corporate office location. This delivery order falls under...
- The Defense Logistics Agency awarded a delivery order valued at $3,684.34 to AmerisourceBergen Drug Corp for the supply of Abilify Maintena ER 400 mg syringes. This firm fixed-price contract, awarded on July 29, 2025, with an ultimate completion date of July 30, 2025, represents a non-set-aside competitive procurement. The work will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under the company's broader Indefinite...
- The Defense Logistics Agency awarded a delivery order valued at $2,681.49 to AmerisourceBergen Drug Corp for the supply of Abilify Maintena ER 400 mg syringes, with an ultimate completion date of July 23, 2025. This is a firm fixed-price delivery order with no set-aside designation, issued competitively to the prime contractor's corporate office located in Conshohocken, Pennsylvania. The award represents a continuation of AmerisourceBergen's role as a critical pharmaceutical supplier within...
- The Defense Logistics Agency awarded a delivery order valued at $1,642.07 to AmerisourceBergen Drug Corp on August 28, 2025, for the supply of Abilify Maintena ER 300 mg syringes. This is a firm fixed-price delivery order with an ultimate completion date of August 29, 2025. The award was made on a competitive basis with no set-aside designation, and the place of performance is AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. This delivery order represents a child contract...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $2,764.94 on July 23, 2025, for the supply of Abilify Maintena ER 300 mg vials/syringes/cartridges. This firm fixed price delivery order, with an ultimate completion date of July 24, 2025, represents a child contract under AmerisourceBergen's larger pharmaceutical supply framework with the federal government. The award was not designated as a set-aside contract and was competitively awarded. Performance...
- The Defense Logistics Agency awarded a $5,533.12 firm fixed-price delivery order to AmerisourceBergen Drug Corp for Abilify Maintena ER 300 mg syringes, with an ultimate completion date of July 25, 2025. This non-set-aside competitive award was issued on July 24, 2025, and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and critical vendor for federal medical procurement, serves as...
- This delivery order, valued at $2,807.89, was awarded on July 18, 2025, by the Defense Logistics Agency to AmerisourceBergen Drug Corp for the supply of Abilify Maintena ER 400 mg syringes. The contract employs firm fixed-price pricing and is scheduled for completion by July 21, 2025. This award represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and valued at $999,999,999.00 through December 2026. No...
- The Defense Logistics Agency (DLA) awarded a $3,912.13 firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a for-profit pharmaceutical distribution company, to provide Abilify Maintena ER 400 mg syringes. This delivery order is part of a larger indefinite delivery contract (IDC) awarded solely to Amerisourcebergen Drug Corp, which has a potential value of $999,999,999.00 and runs through December 31, 2025. The IDC serves as the primary vehicle for Amerisourcebergen to...
- SPE2DB22D3501Indefinite Delivery Contract
- SPE2DB22D3501-SPE2DB25FXH27Delivery Order
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 12, 2025, for the supply of Abilify Maintena ER 400 mg syringes under a firm fixed-price contract with a ceiling value of $2,677.37. This is a non-set-aside, competitively awarded delivery order with an ultimate completion date of September 15, 2025. The contract will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00 and extending through December 2026. The parent IDC serves as a comprehensive global pharmaceutical support vehicle enabling AmerisourceBergen to supply a broad range of medications, vaccines, and medical supplies to support military healthcare programs worldwide. Abilify Maintena ER is an antipsychotic medication used in psychiatric treatment, and this delivery order fulfills specific demand requirements within the Defense Health Agency's medical supply chain for this therapeutic product.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $2.7k | 9/12/25 |